10-12 September 2018 //  Lancaster Royal Hotel, London

Women in Cell & Gene Therapy

The cell and gene therapy industry is currently expanding rapidly and recruitment is becoming more of a focus for organizations, however despite expansion there is still a lack of diversity running throughout the sector. In an age when Hilary Clinton is the presidential candidate of the Democrats in the US, still only 4% of leadership roles within cell and gene therapy are held by women.

With the hope that this current recruitment drive throughout the industry will start to address this gender imbalance, Phacilitate are excited to celebrate the exceptional women already driving innovation in the sector in our new e-book:

The Most Influential Women in Cell & Gene Therapy.


We would like to thank Stacey Johnson of CCRM, Claudia Zylberberg of Akron Biotech and Susan Nichols of Invetech for their help in curating this e-book.

If you'd like to sign-up for updates on future events and initiatives organised by 'Women in Cell & Gene Therapy', click here.

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad